Skip to main content

Takeda Pharmaceutical Value Stock - Dividend - Research Selection

Takeda Pharmaceutical Co Ltd

ISIN: JP3463000004, WKN: 853849

Market price date: 16.07.2021
Market price: 3.736,00 JPY

Takeda Pharmaceutical Co Ltd Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 15-05-2021
Cash flow
Net operating cash flow 1.010.930.000.000
Capital Expenditures -
Free cash flow 899.724.017.664
Balance sheet
Total Equity
Liabilities & Shareholders equity 12.912.300.000.000
Income statement
Net income 376.005.000.000
Eps (diluted) 238,960
Diluted shares outstanding 1.563.360.000
Net sales/revenue 3.197.810.000.000

Fundamental ratios calculated on: 16-07-2021

Key figures 16-07-2021
Cash flow
P/C 5,78
P/FC 6,49
Balance sheet
Income statement
Div. Yield4,82%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization56.311.226.368,00 USD
IndicesNIKKEI 225
Raw Data SourceIFRS in Millionen JPY
Stock Split

Description of the company

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. As of March 31, 2014, the Company had 146 subsidiaries and 17 associated companies.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,